The latest announcement is out from Dr. Hoenle AG ( (DE:HNL) ).
Dr. Hönle AG, based in Gilching, Germany, announced a change in voting rights, with FundPartner Solutions (Europe) S.A. reducing its stake from 3.19% to 2.99% of voting rights attached to shares. This adjustment reflects a disposal of shares impacting the company’s shareholding structure, potentially influencing its strategic decisions and shareholder dynamics.
More about Dr. Hoenle AG
YTD Price Performance: 35.46%
Average Trading Volume: 5,525
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €62.13M
For detailed information about HNL stock, go to TipRanks’ Stock Analysis page.